This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Magnetic Resonance Imaging (MRI) Contrast Agents Market

Market Insights on Magnetic Resonance Imaging (MRI) Contrast Agents covering sales outlook, demand forecast & up-to-date key trends

Magnetic Resonance Imaging (MRI) Contrast Agents Market, by Product Type (Paramagnetic Contrast Agents and Super Magnetic Contrast Agents) & Region - Forecast 2022 - 2029

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Snapshot

[240 Pages Report]  The global Magnetic Resonance Imaging (MRI) Contrast Agents Market recorded sales worth U.S. $ 871.0 Mn in the year 2021. The market is expected to grow 1.3X over the forecast period 2022-2029. The industry will record sales worth U.S. $ 1.23 Bn by the end of 2029.

Data Points

Market Insights

Market Value 2022

U.S. $ 910.9 Mn

Market Value 2029

U.S. $ 1.23 Bn

CAGR 2022-2029

4.4%

Share of top 5 countries

60.8%

Key Players

The key players of the magnetic resonance imaging (MRI) contrast agents market are Bayer AG, GE Healthcare, LLC, Guerbet GmbH, Bracco Imaging SpA, and Miltenyi Biotec B.V. & Co. Kg.

In 2021, the magnetic resonance imaging (MRI) contrast agents market accounted for around 17.8% revenue share of the global contrast agents market revenue which was recorded to be around U.S. $ 4.9 Bn. MRI scans have become one of the most commonly used diagnostic tools to ascertain the presence of tumours, clots, aneurysms, vessel structure issues and much more. The high adoption rate of this scanning technique is a key factor attributing to the expansion of this market globally.

The contrast agents or dyes when injected into the body before an MRI scan improve the quality of the images by increasing the contrast between normal and diseased tissues in the body. Paramagnetic contrast agents, which are gadolinium ion-based contrast agents are most commonly used to visualize the internal body tissues for diagnostic purposes.

The global MRI contrast agents market is expected to grow at a steady pace over the forecast period (2022-2029) due to the growing preference for imaging technology for disease diagnosis and the increasing number of MRI scanner installations around the world. According to the data published by the Organization of Economic Co-operation and Development (OECD), Japan had the highest density of MRI scanner installation in the year 2019 with 55 MRI scanning units per million populations in the country.

The Healthcare sector across the globe is going through a paradigm shift and is focusing on value-based models for offering better care to the consumers, all the regulatory authorities around the world are assisting in this development by making the product approval process easier for this industry.

Non-invasive treatment methodology and multimodal diagnostic imaging services are experiencing a high adoption rate over the past few years which is seen to positively impact the growth of the global magnetic resonance imaging (MRI) contrast agents market.

Paramagnetic contrast agents accounted for more than 99% market share, by the value of the total magnetic resonance imaging (MRI) contrast agents market in the year 2021 with the recorded sales worth U.S. $ 863.8 Mn in the same year. The increasing burden of non-communicable diseases around the world is a key factor driving the sales of the global magnetic resonance imaging (MRI) contrast agents market.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

4.44%

H1, 2022 Projected

4.41%

H1, 2022 Outlook

4.31%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 13 ↓

FMI provides a comparative analysis of the growth rate of the market and developmental prospects in the global magnetic resonance imaging (MRI) contrast agents market. The market growth is influenced by government financial support and growing approvals for contrast agents in accordance with the impact of macro and industry factors.

The key developments in this market include technological advancements in diagnostic imaging and new product launches by market players.

According to Future Market Insight analysis, the magnetic resonance imaging (MRI) contrast agents market is estimated to drop by 10 BPS in H1-2022 - outlook over H1, 2022 projected period. Furthermore, the market will show a drop in BPS change with 13 Basis Point Share (BPS) in H1-2022 (O) compared to H1, 2021.

The major factors for this drop in BPS are attributed to lower utilization of routine testing during COVID-19, and also because people tend to prefer the alternative cost-effective options. The extracellular fluid (ECF) agent segment is expected to perform fairly and attain promising growth prospects in the next half of the projection period.

However, there are some points that will lead the market ahead in the industry, including machine-learning-based image analysis procedures, which will provide lucrative opportunities to improve image contrast in MRI. Also, key players are strategically planning to expand the market reach through collaborations and mergers.

2014-2021 Magnetic Resonance Imaging (MRI) Contrast Agents Demand Outlook Compared to 2022-2029 Forecast

According to Future Market Insights (FMI), the demand for magnetic resonance imaging (MRI) contrast agents during the period of 2014 to 2021 expanded at a CAGR of 4.1%. Growing patient awareness regarding non-invasive diagnostic techniques and their accessibility to healthcare were some of the key reasons for the growth of this market in the past few years.

The number of MRI scans has been continuously increasing due to the growing prevalence of chronic diseases affecting brains, spines and livers and incidences of injuries in joints such as the back and knee. Data published by Organization for Economic Co-operation and Development (OECD), depicts that the number of MRI scans performed in the United States per 1000 population was highest in the world in 2018. The growth of MRI scans performed in the U.S. was increased by about 1.08% that is 109.5 per 1000 population in 2014 to 118.9 per 1000 population in 2018.

The demand for MRI contrast agents has significantly increased in the past few decades because of the rapid procedural advancement in medical imaging technology MRI. To meet the patients’ needs undergoing diagnostic procedures, the key market leaders are now focusing on large scale investments towards uninterrupted and sustainable product supply of contrast agents.

For instance, GE Healthcare invested over 65 million US$ in its worldwide supply network between 2013 and 2016, to increase its manufacturing capacity. The company provides service and supplies contrast media to radiologists across all medical and technical aspects of imaging. GE Healthcare reported that its contrast agents are used in above 70 million procedures per year.

Multimodality imaging takes advantage of different combination imaging modalities in medical imaging to provide a more complete anatomy picture under investigation. MRI is widely used in both therapeutic and diagnostic applications due to its multi-planner imaging capability, sensitivity to subtle changes in soft tissue function and morphology and high signal to noise ratio.

Molecular imaging devices are usually integrated with CT (computed tomography) and MRI scanners to correlate the anatomical location with biological processes in the body. Computers are used to fuse anatomical images and biological processes to help clinicians make better therapeutic and diagnostic decisions. Wider the applications of the scanner, more is the adoption of the product.

COVID-19 pandemic harmed the MRI contrast agents market because the pandemic reduced patient footfall to the hospitals and diagnostic centres due to the infection scare. Reduced patient volume affected the market negatively in the year 2020.

The magnetic resonance imaging (MRI) contrast agents market key players are focusing on getting various regulatory agencies approvals for expanding their product portfolio of MRI contrast agents around the world.

For instance, Bayer AG in July 2019, announced the FDA approval of their Gadavist®, which is a gadobutrol injection, one of its kind contrast agent for cardiac MRI for the detection and monitoring of coronary artery disease.

In November 2019, GE Healthcare announced the FDA approval of their MRI contrast agent Clariscan™, which is a gadolinium-based, macrocyclic, ionic. This contrast agent is used to visualize the disruption of the blood-brain barrier or any abnormal vascularity in both adult and paediatric patients.

The same contrast agent, Clariscan™ was launched by GE Healthcare in the 2017 meeting of the European Congress of Radiology.

Magnetic Resonance Imaging (MRI) Contrast Agents Market Download Report Brochure

The magnetic resonance imaging (MRI) contrast agents market is consolidated with a few key players such as Bayer AG, GE Healthcare, LLC, Guerbet GmbH, Bracco Imaging SpA, and Miltenyi Biotec B.V. & Co. Kg.

Future Market Insights expects the global magnetic resonance imaging (MRI) contrast agents market to expand at the cumulative CAGR of 4.4% over the forecast period (2022-2029) since many of the key players are focusing their efforts to expand their businesses around the world.

What is the impact of COVID-19 on this industry?

Due to fewer patient visits to hospitals, the COVID-19 outbreak had a detrimental impact on the magnetic resonance imaging (MRI) contrast agents’ industry. Healthcare systems have been severely strained as a result of the pandemic.

To prevent the spread of the disease and conserve healthcare resources for COVID-19 patients, healthcare institutes and providers were told to halt performing elective surgical operations and medical evaluations. As a result, the volume of imaging cases in many radiology departments dropped dramatically.

The contrast media/ contrast agents market has been impacted by decreased use of contrast media/ contrast agents due to a decline in the volume of elective and non-essential procedures, lower utilisation of routine testing, reduced capital spending by customers, and a decrease in research activity due to laboratory closures and reduced clinical testing.

What are the key opportunities for the manufacturers of magnetic resonance imaging (MRI) contrast agents?

MRI contrast agents are increasingly being used in the diagnosis of chronic diseases using MRI technology. According to WHO, chronic diseases will account for three-quarters of global deaths by 2020. Chronic diseases can be preventable if patients are diagnosed at an early stage.

However, up until now, only four to five companies such as Bayer AG, GE Healthcare LLC, Guerbet GmbH and Bracco Imaging SpA are actively involved in the manufacturing of MRI contrast agents globally, which will create some huge opportunities for other small as well as big manufacturers to enter the MRI contrast agents market.

Various initiatives taken by the government to develop modern healthcare centres and also provide financial support to develop new MRI machines are one of the key trends driving the magnetic resonance imaging (MRI) contrast agents market growth.

Continuous investments by the government for the treatment of cancer and chronic disorders is the key factor that provides opportunities for MRI contrast agents market players to develop and expand their sale of MRI contrast agents in emerging markets.

In March 2018, the government of India announced the development of indigenous low-cost MRI machines in the meeting of the Society for Applied Microwave Electronics Engineering & Research (SAMEER, under the MeitY) to bring down the cost of scan for patients.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the restraining factors for this market?

All approved contrast agents contain gadolinium - a chemical element, which is toxic in its free form. Binding agents or cheaters are used to make gadolinium safe for use in humans, to prevent the deposition of metals in the body.

However, some concerns have been raised in recent studies that not all the gadolinium injected for the scan are eliminated from the body, and some traces of gadolinium left in tissues may cause harm to the body in the long term, which is expected to restrain the market growth.

In most cases, physicians do not prefer contrast media during the MRI scan as it was found toxic and harmful to some extent. Alternative methods are cost-effective and fast as compared to the MRI contrast agent diagnosis method.

Ultrasound is a real-time method of investigation, which offers contrast-enhanced imaging with safety and cost-effective medical imaging possibly restraining the MRI contrast agents market.  Also, X-ray and CT scans are good alternatives for MRI scans, which can produce nearly equivalent test results anticipated to restrain the MRI contrast agents market growth.

In developing countries, the cost of MRI diagnosis is not pocket-friendly, restricting the adoption of MRI techniques for diagnosis. Hence, this may slow down the growth of the market. MRI contrast agents are available at a reasonable cost, but the cost of an MRI scan is very high. Due to this, patients, as well as physicians, also think twice before they use MRI for disease diagnosis in developing countries.

Country-wise Insights

Will the U.S. remain a key market for magnetic resonance imaging (MRI) contrast agents?

The U.S. accounted for 94.4% market share, by the value of the MRI contrast agents in North America in 2021 and is expected to expand at a CAGR of 4.5% over the forecast period. According to the Centre for Disease Control and Prevention, around 18.2 million people in the U.S. suffered from coronary heart disease (CHD) in the year 2017. MRI contrast is one of the preferred techniques to diagnose CHD, hence the high market shares of the U.S.

How is the magnetic resonance imaging (MRI) contrast agents market in Germany?

The sales of magnetic resonance imaging (MRI) contrast agents in Germany were recorded to be U.S. $ 66.9 Mn in the year 2021 and is expected to grow 1.5X by the end of 2029 with a cumulative CAGR of 5.9% over the forecast period. According to the Organization of Economic Co-operation and Development (OCED), there were around 35 MRI scanners installed per one million people in Germany in the year 2018. With the high rate of production adoption seen in Germany, the country accounts for this high share in Europe.

Will India be a key market for magnetic resonance imaging (MRI) contrast agents in South Asia?

The sales of MRI contrast agents in India were recorded to be U.S. $ 42.5 Mn in the year 2021, which accounted for 58.2% market share, by the value of the market in South Asia. Increasing government initiatives to offer low-cost MRI scanning to the consumers in India are contributing to the high product adoption rate in India. According to an article published by the Tata School of Social Studies, over 9.2 lakh MRI scans were performed in Chennai alone, in the year 2019, which was because the state government slashed the price to half in the same year.

How does the magnetic resonance imaging (MRI) contrast agents market look in China?

China accounted for approximately half of the total MRI contrast agents market in East Asia in the year 2021. The Chinese market for these contrast agents is expected to expand at a CAGR of 6.4% over the forecast year with the estimated sales of U.S. $ 88.5 Mn by the end of 2029. Since China is a key raw material provider for the manufacturers of MRI contrast agents around the world, it is attributed to the high market share in the East Asian market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

What is the magnetic resonance imaging (MRI) contrast agents market value?

The magnetic resonance imaging (MRI) contrast agents market recorded sales worth U.S. $ 871.0 Mn in the year 2021 and the market is expected to expand 1.35X by the end of 2029. The industry is anticipated to grow at a CAGR of 4.4% over the forecast period due to the increasing demand for precise and cost-effective diagnostic techniques around the world.

Why are paramagnetic contrast agents holding the largest market share, by product type?

Paramagnetic contrast agents are of three types viz. extracellular fluid (ECF) agents, organ-specific agents and blood pool contrast agents (BPCAs). The extracellular fluid contrast agents are the most commonly used paramagnetic contrast agents as they have a variety of applications in the diagnosis of diseases related to head and neck, blood vessels, blood-brain barrier, bone tissue examinations and much more.

Due to the aforementioned reasons, the paramagnetic contrast agents accounted for more than 99% of the total market share, by the value of the magnetic resonance imaging (MRI) contrast agents market in the year 2021 and will continue a similar trend over the forecast period.

Which end-user contributes the highest share in the magnetic resonance imaging (MRI) contrast agents market?

Hospitals accounted for nearly 54% of the market share, by the value of the global MRI contrast agents’ industry in the year 2021 with sales worth U.S. $ 473.6 Mn in the same year. Hospital sales are expected to expand at a CAGR of 4.4% over the forecast period. Hospitals are the go-to centres for all the patients seeking major diagnostic tests around the world. All chronic illnesses are treated in the hospitals, which explains the high market share.

Competitive Landscape:

The key players of this industry are working on expanding their product portfolio through strategic partnerships, acquisitions and mergers, and achieving FDA approvals.

For Instance, in November 2019, Guerbet announced a strategic partnership with InterSystems, to expand the scope of their Contrast&Care® which is a contrast media injection management solution to optimize and effectively integrate this patient data management tool in the hospitals and various imaging centres.

In August 2019, Bracco Imaging announced the acquisition of Blue Earth Diagnostics to broaden its product portfolios in precision medicine and personalized diagnostics.

In December 2020, Bracco Diagnostics Inc., which is a U.S. subsidiary of Bracco imaging S.p.A, announced the FDA approval of their ProHance®, which is a Gadoteridol injection, 279.3 mg/mL used intravenously for MRI scanning, in neonate patients to visualize the disruption of the blood-brain barrier or any other abnormal activities in brain and spine.

Scope of the Report:

Attributes

Details

Forecast Period

2022-2029

Historic Data available for

2014-2021

Market Analysis

USD Million for value

Key Countries covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa.

Key Segments covered

Product Type, End-User & Country.

Key Companies Profiled

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization and Pricing

Available upon request

Magnetic Resonance Imaging (MRI) Contrast Agents Market, By Category

By Product Type:

  • Paramagnetic Contrast Agents
    • Extracellular Fluid (ECF) Agents
    • Organ-Specific Agents
    • Blood Pool Contrast Agents (BPCAs)
  • Supermagnetic Contrast Agent

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Frequently Asked Questions

Paramagnetic contrast agents and supermagnetic contrast agents are used in MRI contrast scans.

The magnetic resonance imaging (MRI) contrast agents market is expected to grow at a cumulative CAGR of 4.4% over the forecast period 2022-2029.

The magnetic resonance imaging (MRI) contrast agents market recorded sales worth U.S. $ 871.0 Mn in the year 2021 and is expected to be worth U.S. $ 1.23 Bn by the end of 2029.

The key players of the magnetic resonance imaging (MRI) contrast agents market are Bayer AG, GE Healthcare, LLC, Guerbet GmbH, Bracco Imaging SpA, and Miltenyi Biotec B.V. & Co. Kg.

The paramagnetic contrast agents dominated the MRI contrast agents market with a market share as high are 99.2% in the year 2021.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Key Inclusions and Exclusions

3. Key Market Trends

4. Key Success Factors

    4.1. Parent Market Analysis

    4.2. Product Adoption by region

    4.3. Development of Combination Imaging Modalities

    4.4. Identifying Novel Use Cases

    4.5. Product USPs / Features

    4.6. Number of Scans by Region

5. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Volume (Units) Analysis 2014-2021 and Forecast, 2022-2029

    5.1. Current Installed Base of MRI Units, by Region / Country

    5.2. Historical Market Volume (Units) Analysis, 2014-2021

    5.3. Current and Future Market Volume (Units) Projections, 2022-2029

        5.3.1. Y-o-Y Growth Trend Analysis and Projections

6. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market - Pricing Analysis

7. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Value (US$) Analysis 2014-2021 and Forecast, 2022-2029

    7.1. Historical Market Value (US$ Mn) Analysis, 2014-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Macro-Economic Factors

    8.2. Forecast Factors - Relevance & Impact

    8.3. Reimbursement Scenario

    8.4. Regulatory Scenario

    8.5. Products in Development: Pipeline Assessment and Opportunity Analysis

    8.6. Value Chain Analysis

    8.7. Market Dynamics

        8.7.1. Drivers

        8.7.2. Restraints

        8.7.3. Opportunity Analysis

9. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029, By Product Type 

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2014-2021

    9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2022-2029

        9.3.1. Paramagnetic Contrast Agents

                9.3.1.1.1. Extracellular Fluid (ECF) Agents

                9.3.1.1.2. Blood Pool Contrast Agents (BPCAs)

                9.3.1.1.3. Organ-Specific Agents

        9.3.2. Superparamagnetic Contrast Agents

    9.4. Market Attractiveness Analysis By Product Type 

10. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029, By End User 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User, 2014-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2029

        10.3.1. Hospitals

        10.3.2. Ambulatory Surgical Centers

        10.3.3. Diagnostic Centers 

    10.4. Market Attractiveness Analysis By End User 

11. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2029

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia 

        11.3.6. MEA

        11.3.7. Oceania

    11.4. Market Attractiveness Analysis By Region

12. North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        12.3.1.  By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Product Type

        12.3.3. By End User 

    12.4. Market Attractiveness Analysis

    12.5. Drivers and Restraints - Impact Analysis

13. Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Product Type

        13.3.3. By End User 

    13.4. Market Attractiveness Analysis

    13.5. Drivers and Restraints - Impact Analysis

14. Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Product Type

        14.3.3. By End User 

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Product Type

        15.3.3. By End User 

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Product Type

        16.3.3. By End User 

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints - Impact Analysis

17. Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Product Type

        17.3.3. By End User 

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029

        18.3.1.  By Country

            18.3.1.1. GCC Countries

            18.3.1.2. South Africa

            18.3.1.3. Rest of Middle East and Africa

        18.3.2. By Product Type

        18.3.3. By End User 

    18.4. Market Attractiveness Analysis

    18.5. Drivers and Restraints - Impact Analysis

19. Emerging Countries Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis 2014-2021 and Forecast 2022-2029

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. China Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis

        19.2.1. Introduction

        19.2.2. Market Value Proportion Analysis by Market Taxonomy

        19.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            19.2.3.1. By Product Type

            19.2.3.2. By End User 

    19.3. India Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis

        19.3.1. Introduction

        19.3.2. Market Value Proportion Analysis by Market Taxonomy

        19.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            19.3.3.1. By Product Type

            19.3.3.2. By End User 

        19.3.4. Market Attractiveness Analysis

        19.3.5. Market Attractiveness Analysis

    19.4. South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis

        19.4.1. Introduction

        19.4.2. Market Value Proportion Analysis by Market Taxonomy

        19.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            19.4.3.1. By Product Type

            19.4.3.2. By End User 

        19.4.4. Market Attractiveness Analysis

20. Market Structure Analysis

    20.1. Market Share Analysis

    20.2. Brand Share Analysis

    20.3. Market Concentration

    20.4. Competition Mapping 

21. Competition Analysis

    21.1. Company Dashboard

    21.2. Company Deep dive (Tentative List)

        21.2.1. Bayer AG 

            21.2.1.1. Company Overview

            21.2.1.2. Product Overview

            21.2.1.3. Key Financials

            21.2.1.4. Key Developments

            21.2.1.5. Analyst Commentary 

        21.2.2. GE Healthcare LLC

            21.2.2.1. Company Overview

            21.2.2.2. Product Overview

            21.2.2.3. Key Financials

            21.2.2.4. Key Developments

            21.2.2.5. Analyst Commentary

        21.2.3. Guerbet GmbH

            21.2.3.1. Company Overview

            21.2.3.2. Product Overview

            21.2.3.3. Key Financials

            21.2.3.4. Key Developments

            21.2.3.5. Analyst Commentary

        21.2.4. Bracco Imaging SpA

            21.2.4.1. Company Overview

            21.2.4.2. Product Overview

            21.2.4.3. Key Financials

            21.2.4.4. Key Developments

            21.2.4.5. Analyst Commentary

        21.2.5. Miltenyi Biotec B.V. & Co. Kg  

            21.2.5.1. Company Overview

            21.2.5.2. Product Overview

            21.2.5.3. Key Financials

            21.2.5.4. Key Developments

            21.2.5.5. Analyst Commentary

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Magnetic Resonance Imaging (MRI) Contrast Agents Market : Novel Use Cases

Table 02: Magnetic Resonance Imaging (MRI) Contrast Agents Market : Product USPs

Table 03: Magnetic Resonance Imaging (MRI) Contrast Agents Market : Number of Scans by Country

Table 04: Magnetic Resonance Imaging (MRI) Contrast Agents Market : Installed Based MRI Units by Country

Table 05: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Region

Table 06: Expenditure on Healthcare, (% of GDP), by Country, 2016 - 2021

Table 07: Expenditure on Healthcare, (% of GDP), by Country, 2016 - 2021

Table 08: CPT code for MRI with Contrast Agent

Table 09: CPT code for MRI with Contrast Agent

Table 10: CPT code for MRI with Contrast Agent

Table 11: MRI Contrast Agents Market :  Pipeline Assessment and Opportunity Analysis

Table 12: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 13: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 14: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, by End User 

Table 15: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region

Table 16: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 17: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 18: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 19: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 20: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 21: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 22: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 23: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 24: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 25: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 26: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 27: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 28: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 29: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 30: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 31: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 32: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 33: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 34: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 35: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 36: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 37: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 38: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 39: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 40: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 41: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 42: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 43: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Table 44: China Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 45: China Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 46: China Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 47: India Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 48: India Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 49: India Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Table 50: South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 51: South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Volume (in Liters) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Table 52: South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End Use

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Region–2022 & 2029

Figure 02: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Y-o-Y Growth Projections by Region, 2022 – 2029

Figure 03: Regional Average Pricing Analysis (US$) of Extracellular Fluid (ECF) Agents, (2021A)

Figure 04: Regional Average Pricing Analysis (US$) of Organ-Specific Agents, (2021A)

Figure 05: Regional Average Pricing Analysis (US$) of Blood Pool Contrast Agents (BPCAs), (2021A)

Figure 06: Regional Average Pricing Analysis (US$) of Supermagnetic Contrast Agent, (2021A)

Figure 07: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 08: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022 – 2029

Figure 09: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Absolute $ Opportunity Analysis, 2022 – 2029

Figure 10: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Product Type –2022 & 2029

Figure 11: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Y-o-Y Growth Projections by Product Type , 2022 – 2029

Figure 12: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 13: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by End User –2022 & 2029

Figure 14: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Y-o-Y Growth Projections by End User , 2022 – 2029

Figure 15: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User 

Figure 16: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Region–2022 & 2029

Figure 17: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Y-o-Y Growth Projections by Region, 2022 – 2029

Figure 18: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region

Figure 19: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 20: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 21: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 22: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 23: North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Figure 24: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 25: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 26: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 27: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 28: Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Figure 29: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 30: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 31: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 32: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 33: Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Figure 34: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 35: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 36: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 37: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 38: East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Figure 39: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 40: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 41: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 42: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 43: South Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Figure 44: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 45: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 46: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 47: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 48: Oceania Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Figure 49: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 50: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 51: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 52: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 53: Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country

Figure 54: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Value Proportion Analysis, By Emerging Countries, 2022 (E)

Figure 55: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Global Vs. Country Y-o-Y (%) Growth Comparison, 2022-2029

Figure 56: China Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 57: China Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 58: China Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 59: China Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 60: India Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 61: India Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 62: India Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 63: India Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 64: South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis, 2014-2021

Figure 65: South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) & Y-o-Y Growth (%), 2022 – 2029

Figure 66: South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type

Figure 67: South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User

Figure 68: Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Share (%) Analysis

Figure 69: Global MRI Contrast Agents Market: Brand Share Analysis Share Analysis (2021)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Medical X-Ray Detectors Market

Published : March 2022

Healthcare

MRI Pulse Oximeters Market

Published : February 2022

Healthcare

MRI Guided Neurosurgical Ablation Market

Published : December 2021

Healthcare

Molecular Imaging Market

Published : April 2021

Google translate

Magnetic Resonance Imaging (MRI) Contrast Agents Market